Results 181 to 190 of about 675,123 (288)

Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study. [PDF]

Endocrine, 2021
Kuhn E, Caron P, Delemer B, Raingeard I, Lefebvre H, Raverot G, Cortet-Rudelli C, Desailloud R, Geffroy C, Henocque R, Brault Y, Brue T, Chanson P.   +12 more
europepmc   +1 more source

The clinical use of somatostatin analogues in the treatment of cancer [PDF]

, 1990
Klijn, J.G.M. (Jan), Krenning, E.P. (Eric), Lamberts, S.W.J. (Steven), Reubi, J.-C. (Jean-Claude)   +3 more
core   +1 more source

Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs. [PDF]

J Neuroendocrinol
Polici M, Caruso D, Masci B, Marasco M, Valanzuolo D, Dell'Unto E, Zerunian M, Campana D, De Santis D, Lamberti G, Iannicelli E, Prosperi D, Annibale B, Laghi A, Panzuto F, Rinzivillo M.   +15 more
europepmc   +1 more source

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review. [PDF]

Adv Ther, 2021
Cella D, Evans J, Feuilly M, Neggers S, Van Genechten D, Herman J, Khan MS.   +6 more
europepmc   +1 more source

Somatostatin analogs in the treatment of gastrointestinal angiodysplasia bleeding: a systematic review. [PDF]

Gastroenterol Hepatol Bed Bench
Correa TL, Antunes VLJ, Bulhoes E, Bolner G, Martins OC, de Mesquita CF, Fernandes MV, Milioli NJ, Baraldo S.   +8 more
europepmc   +1 more source

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study. [PDF]

Endocrine, 2021
Kuhn E, Caron P, Delemer B, Raingeard I, Lefebvre H, Raverot G, Cortet-Rudelli C, Desailloud R, Geffroy C, Henocque R, Brault Y, Brue T, Chanson P.   +12 more
europepmc   +1 more source

From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. [PDF]

Ther Adv Med Oncol
Melhorn P, Mazal P, Wolff L, Kretschmer-Chott E, Raderer M, Kiesewetter B.   +5 more
europepmc   +1 more source

Somatostatin analogs: does pharmacology impact antitumor efficacy?

Trends in endocrinology and metabolism, 2014
M. Chalabi, Camille Duluc, P. Caron, D. Vezzosi, J. Guillermet‐Guibert, S. Pyronnet, C. Bousquet   +6 more
semanticscholar   +1 more source

Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.

Journal of Clinical Endocrinology and Metabolism, 2014
S. Neggers, S. Franck, F. D. Rooij, A. Dallenga, R. Poublon, R. Feelders, J. Janssen, M. Buchfelder, L. Hofland, Jens Otto Lunde Jørgensen, A. V. D. Lely   +10 more
semanticscholar   +1 more source

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.

Journal of Clinical Endocrinology and Metabolism, 2013
F. Gatto, R. Feelders, R. van der Pas, J. Kros, M. Waaijers, D. Sprij-Mooij, S. Neggers, A. van der Lelij, F. Minuto, S. Lamberts, W. D. de Herder, D. Ferone, L. Hofland   +12 more
semanticscholar   +1 more source